Magnetic resonance imaging and prediction of outcome in patients with major depressive disorder

Journal of Psychiatry and Neuroscience

Volumn 34, Issue 5, 2009, Pages 343-349

  MacQueen, Glenda M ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BRAIN DERIVED NEUROTROPHIC FACTOR; FLUOXETINE;

AMINO ACID SUBSTITUTION; BRAIN BLOOD FLOW; BRAIN SIZE; CINGULATE GYRUS; COGNITIVE THERAPY; DIFFUSION TENSOR IMAGING; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GENETIC POLYMORPHISM; GLUCOSE TRANSPORT; HAMILTON SCALE; HIPPOCAMPUS; HUMAN; MAJOR DEPRESSION; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; POSITRON EMISSION TOMOGRAPHY; PREDICTION; PREFRONTAL CORTEX; PSYCHOTHERAPY; REMISSION; REVIEW; TREATMENT RESPONSE; BRAIN; METHODOLOGY; PATHOLOGY; PATHOPHYSIOLOGY; PROGNOSIS;

BRAIN; DEPRESSIVE DISORDER, MAJOR; HUMANS; MAGNETIC RESONANCE IMAGING; PROGNOSIS;

EID: 70350497333     PISSN: 11804882     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (67)

1. Ciumas C., Montavont A., Ryvlin P. Magnetic resonance imaging in clinical trials. Curr Opin Neurol 2008;21:431-436
2. Rizvi SA, Agius MA. Current approved options for treating patients with multiple sclerosis. Neurology 2004;63:S8-14.
3. Chen CH, Ridler K, Suckling J, et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007;62:407-414 (Pubitemid 47284016)
4. Mayberg HS, Brannan SK, Tekell JL, et al. Regional metabolic effects of fluoxetine in major depression: serial changes and relationship to clinical response. Biol Psychiatry 2000;48:830-843
5. Pittenger C, Duman RS. Stress, depression, and neuroplasticity: a convergence of mechanisms. Neuropsychopharmacology 2008;33:88-109. (Pubitemid 350191319)
6. Schmidt R, Ropele S, Pendl B, et al. Longitudinal multimodal imaging in mild to moderate Alzheimer disease: a pilot study with memantine. J Neurol Neurosurg Psychiatry 2008;79:1312-1317
7. Lemieux L. Causes, relationships and explanations: the power and limitations of observational longitudinal imaging studies. Curr Opin Neurol 2008;21:391-392
8. Maguire EA, Gadian DG, Johnsrude IS, et al. Navigation-related structural change in the hippocampi of taxi drivers. Proc Natl Acad Sci U S A 2000;97:4398-4403
9. Whitwell JL. Longitudinal imaging: change and causality. Curr Opin Neurol 2008;21:410-416
10. McKinnon MC, Yucel K, Nazarov A, et al. A meta-analysis examining clinical predictors of hippocampal volume in patients with major depressive disorder. J Psychiatry Neurosci 2009;34:41-54.
11. Videbech P, Ravnkilde B. Hippocampal volume and depression: a meta-analysis of MRI studies. Am J Psychiatry 2004;161:1957-1966 (Pubitemid 39441394)
12. Campbell S, Marriott M, Nahmias C, et al. Lower hippocampal volume in patients suffering from depression: a meta-analysis. Am J Psychiatry 2004;161:598-607. (Pubitemid 38445502)
13. Vakili K., Pillay SS, Lafer B, et al. Hippocampal volume in primary unipolar major depression: a magnetic resonance imaging study. Biol Psychiatry 2000;47:1087-1090 (Pubitemid 30336218)
14. MacQueen GM, Yucel K, Taylor VH, et al. Posterior hippocampal volumes are associated with remission rates in patients with major depressive disorder. Biol Psychiatry. 2008;64:880-883
15. Hsieh M.H., McQuoid D.R., Levy R.M., et al. Hippocampal volume and antidepressant response in geriatric depression. Int J Geriatr Psychiatry 2002;17:519-525 (Pubitemid 34678703)
16. Frodl T, Meisenzahl EM, Zetzsche T, et al. Hippocampal and amygdala changes in patients with major depressive disorder and healthy controls during a 1-year follow-up. J Clin Psychiatry 2004;65:492-499
17. Kronmüller KT, Pantel J, Köhler S, et al. Hippocampal volume and two-year outcome in depression. Br J Psychiatry 2008;192:472-473 (Pubitemid 351809903)
18. Frodl T, Jager M, Smajstrlov I, et al. Effect of hippocampal and amygdala volumes on clinical outcomes in major depression: a 3-year prospective magnetic resonance imaging study. J Psychiatry Neurosci 2008;33:423-430
19. Sahay A, Hen R. Adult hippocampal neurogenesis in depression. Nat Neurosci 2007;10:1110-1115
20. Meyer JH. Applying neuroimaging ligands to study major depressive disorder. Semin Nucl Med 2008;38:287-304. (Pubitemid 351726327)
21. Kimbrell TA, Ketter TA, George MS, et al. Regional cerebral glucose utilization in patients with a range of severities of unipolar depression. Biol Psychiatry 2002;51:237-252
22. Saxena S, Brody AL, Ho ML, et al. Differential cerebral metabolic changes with paroxetine treatment of obsessive-compulsive disorder vs major depression. Arch Gen Psychiatry 2002;59:250-261 (Pubitemid 34212502)
23. Videbech P, et al. The Danish PET/depression project: clinical symptoms and cerebral blood flow. A regions-of-interest analysis. Acta Psychiatr Scand 2002;106:35-44. (Pubitemid 34828146)
24. Videbech P, Ravnkilde B, Pedersen TH, et al. The Danish PET/ depression project: PET findings in patients with major depression. Psychol Med 2001;31:1147-1158 (Pubitemid 32975880)
25. Pereira AC, Huddleston DE, Brickman AM, et al. An in vivo correlate of exercise induced neurogenesis in the adult dentate gyrus. Proc Natl Acad Sci U S A 2007;104:5638-5643 (Pubitemid 47175733)
26. Chen CH, Ridler K, Suckling J, et al. Brain imaging correlates of depressive symptom severity and predictors of symptom improvement after antidepressant treatment. Biol Psychiatry 2007;62:407-414 (Pubitemid 47284016)
27. de Lange FP, Koers A, Kalkman JS, et al. Increase in prefrontal cortical volume following cognitive behavioural therapy in patients with chronic fatigue syndrome. Brain 2008;131:2172-2180
28. Alexopoulos GS, Murphy CF, Gunning-Dixon FM, et al. Microstructural white matter abnormalities and remission of geriatric depression. Am J Psychiatry 2008;165:238-244
29. Greicius M. Resting-state functional connectivity in neuropsychiatric disorders. Curr Opin Neurol 2008;21:424-430
30. Raichle ME, Snyder AZ. A default mode of brain function: a brief history of an evolving idea. Neuroimage 2007;37:1083-90, discussion 1097-1099
31. Greicius MD, Krasnow B, Reiss AL, et al. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A 2003;100:253-258 (Pubitemid 36078061)
32. Damoiseaux JS, Rombouts SA, Barkhof F, et al. Consistent resting-state networks across healthy subjects. Proc Natl Acad Sci U S A 2006;103:13848-13853 (Pubitemid 44413996)
33. Vincent JL, Snyder AZ, Fox MD, et al. Coherent spontaneous activity identifies a hippocampal-parietal memory network. J Neurophysiol 2006;96:3517-3531
34. De Luca M, Beckmann CF, De Stefano N, et al. fMRI resting state networks define distinct modes of long-distance interactions in the human brain. Neuroimage 2006;29:1359-1367 (Pubitemid 43184199)
35. Fox MD, Snyder AZ, Vincent JL, et al. The human brain is intrin-sically organized into dynamic, anticorrelated functional networks. Proc Natl Acad Sci U S A 2005;102:9673-9678 (Pubitemid 40981739)
36. Friston KJ, Frith CD, Liddle PF, et al. Functional connectivity: the principal-component analysis of large (PET) data sets. J Cereb Blood Flow Metab 1993;13:5-14. (Pubitemid 23016598)
37. Fox MD, Raichle ME. Spontaneous fluctuations in brain activity observed with functional magnetic resonance imaging. Nat Rev Neurosci 2007;8:700-711 (Pubitemid 47283145)
38. Franco AR, Pritchard A, Calhoun VD, et al. Interrater and inter-method reliability of default mode network selection. Hum Brain Mapp 2009 Feb. 10 [Epub ahead of print].
39. Anand A, Li Y, Wang Y, et al. Activity and connectivity of brain mood regulating circuit in depression: a functional magnetic resonance study. Biol Psychiatry 2005;57:1079-1088 (Pubitemid 40615768)
40. Anand A, Li Y, Wang Y, et al. Antidepressant effect on connectivity of the mood-regulating circuit: an FMRI study. Neuropsycho-pharmacology 2005;30:1334-1344 (Pubitemid 40848087)
41. Greicius MD, Flores BH, Menon V, et al. Resting-state functional connectivity in major depression: abnormally increased contributions from subgenual cingulate cortex and thalamus. Biol Psychiatry 2007;62:429-437 (Pubitemid 47284017)
42. Fu CH, Williams SC, Cleare AJ, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 2008;64:505-512
43. Marquand AF, Mourão-Miranda J, Brammer MJ, et al. Neuro- anatomy of verbal working memory as a diagnostic biomarker for depression. Neuroreport 2008;19:1507-1511
44. Davatzikos C, Shen D, Gur RC, et al. Whole-brain morphometric study of schizophrenia revealing a spatially complex set of focal abnormalities. Arch Gen Psychiatry 2005;62:1218-1227 (Pubitemid 41586921)
45. Zhang L, Samaras D, Tomasi D, et al. Exploiting temporal information in functional magnetic resonance imaging brain data. Med Image Comput Comput Assist Interv Int Conf Med Image Comput Comput Assist Interv 2005;8:679-687 (Pubitemid 43828309)
46. Canli T, Cooney RE, Goldin P, et al. Amygdala reactivity to emotional faces predicts improvement in major depression. Neuroreport 2005;16:1267-1270 (Pubitemid 41225193)
47. Siegle GJ, Carter CS, Thase M. Use of FMRI to predict recovery from unipolar depression with cognitive behavior therapy. Am J Psychiatry 2006;163:735-738 (Pubitemid 44464587)
48. Bryant RA, Felmingham K, Kemp A, et al. Amygdala and ventral anterior cingulate activation predicts treatment response to cognitive behaviour therapy for post-traumatic stress disorder. Psychol Med 2008;38:555-561 (Pubitemid 351354888)
49. Fu CH, Williams SC, Cleare AJ, et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol Psychiatry 2008;64:505-512
50. Forbes EE, Hariri AR, Martin SL, et al. Altered striatal activation predicting real-world positive affect in adolescent major depressive disorder. Am J Psychiatry 2009;166:64-73.
51. DeRubeis RJ, Siegle GJ, Hollon SD. Cognitive therapy versus medication for depression: treatment outcomes and neural mechanisms. Nat Rev Neurosci 2008;9:788-796
52. Kennedy SH, Konarski JZ, Segal ZV, et al. Differences in brain glucose metabolism between responders to CBT and venlafaxine in a 16-week randomized controlled trial. Am J Psychiatry 2007;164:778-788
53. Whalen PJ, Johnstone T, Somerville LH, et al. A functional magnetic resonance imaging predictor of treatment response to venlafaxine in generalized anxiety disorder. Biol Psychiatry 2008; 63:858-863
54. Nitschke JB, Sarinopoulos I, Oathes DJ, et al. Anticipatory activation in the amygdala and anterior cingulate in generalized anxiety disorder and prediction of treatment response. Am J Psychiatry 2009;166:302-310
55. Sen S, Duman R, Sanacora G. Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biol Psychiatry 2008;64:527-532
56. Gervasoni N, Aubry JM, Bondolfi G, et al. Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 2005;51:234-238 (Pubitemid 40976406)
57. Gonul AS, Akdeniz F, Taneli F, et al. Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. Eur Arch Psychiatry Clin Neurosci 2005;255:381-386 (Pubitemid 43029827)
58. Huang TL, Lee CT, Liu YL. Serum brain-derived neurotrophic factor levels in patients with major depression: effects of antidepressants. J Psychiatr Res 2008;42:521-525
59. Aydemir C, Yalcin ES, Aksaray S, et al. Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Prog Neuropsychopharmacol Biol Psychiatry 2006;30:1256-1260 (Pubitemid 44216065)
60. Deveci A, Aydemir O, Taskin O, et al. Serum brain-derived neurotrophic factor levels in conversion disorder: comparative study with depression. Psychiatry Clin Neurosci 2007;61:571-573 (Pubitemid 47414862)
61. Piccinni A, Marazziti D, Catena M, et al. Plasma and serum brain-derived neurotrophic factor (BDNF) in depressed patients during 1 year of antidepressant treatments. J Affect Disord 2008;105:279-283 (Pubitemid 350245688)
62. Ho B-C, Andreasen NC, Dawson JD, et al. Association between brain-derived neurotrophic factor Val66Met gene polymorphism and progressive brain volume changes in schizophrenia. Am J Psychiatry 2007;164:1890-1899 (Pubitemid 351739243)
63. Ho BC, Milev P, O'Leary DS, et al. Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. Arch Gen Psychiatry 2006;63:731-740
64. Gatt JM, Nemeroff CB, Dobson-Stone C, et al. Interactions between BDNF Val66Met polymorphism and early life stress predict brain and arousal pathways to syndromal depression and anxiety. Mol Pscyhiatry 2009 Jan. 20 [Epub ahead of print].
65. Foster JA, MacQueen G. Neurobiological factors linking personality traits and major depression. Can J Psychiatry 2008;53:6-13. (Pubitemid 351235836)
66. Warner-Schmidt JL, Duman RS. VEGF as a potential target for therapeutic intervention in depression. Curr Opin Pharmacol 2008;8:14-19 (Pubitemid 351168696)
67. Miresco MJ, Kirmayer LJ. The persistence of mind-brain dualism in psychiatric reasoning about clinical scenarios. Am J Psychiatry 2006;163:913-918